Functionalized polymeric nanoparticles hold great promise as potential drug delivery vehicles in terms of controlled drug release, reduced cell toxicity, and better therapeutic efficacy.
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Among a variety of polymeric materials that can be used for preparing nanoparticles, poly(lactic-co-glycolic acid) (PLGA) has attracted particular attention due to its optimal properties such as biocompatibility and biodegradability. 3 PLGA nanoparticles have been successfully employed to deliver drugs and bioactive agents in vivo. 4 The loaded drug can be released from PLGA nanoparticles in a controlled and sustained manner upon degradation of the polymer. 5 A critical parameter in evaluating the performance of PLGA nanoparticles is the particle size. 6 Nanoparticles smaller than 100 nm have a prolonged circulation half-time than those larger than 200 nm. The smaller nanoparticles also show a higher rate of cellular uptake than larger ones. 7, 8 Conventional approaches for preparing drugloaded PLGA nanoparticles include emulsion-solvent evaporation, nanoprecipitation and polymerization.
9 Among these techniques, nanoprecipitation can easily produce small PLGA nanoparticles (<100 nm) by dissolving the polymer and drug in organic solution followed by adding aqueous solution. However, these PLGA nanoparticles have a broad size distribution as a result of poor control over mixing in bulk. Microuidics-based methods allow rapid mixing and precise control of different streams, and provide a simple means to prepare polymeric nanoparticles with narrow size distribution. [10] [11] [12] For example, hydrodynamic ow focusing and passive mixing enhanced by particular microstructures have been applied to fabricate homogeneous PLGA-PEG nanoparticles with diameters of tens of nanometers. 13 In this work we propose a microuidic origami chip with different geometries that enables rapid mixing of PLGA-doxorubicin (DOX) solution and water, resulting in monodisperse DOX-loaded PLGA nanoparticles with a controllable size from 70 to 230 nm in a single nanoprecipitation step. The cellular uptake and anticancer efficiency of synthesized PLGA-DOX nanoparticles are investigated. This foldable microuidic origami chip is highly versatile and can be applied to prepare a variety of polymeric nanoparticles by nanoprecipitation.
The microuidic origami chip is made by bonding two polydimethylsiloxane (PDMS) layers aer oxygen plasma. The two 500 mm thick PDMS layers are obtained by spin-coating uncured PDMS on the surface of silicon wafer at 500 rpm for 30 s. The top layer contains an embedded microuidic channel (300 Â 300 mm cross-section and 6 cm long) with three inlets and one outlet. The bottom layer is a at PDMS slab. The assembled origami chip can be manually folded to form different geometries such as arc and double spiral ( Fig. 1 and S1, for details see ESI †).
14-16
In the experiments, PLGA-DOX nanoparticles were precipitated through rapid mixing of one organic stream in the middle inlet channel and two water streams in the side inlet channels (Fig. 1) . The organic solution (2% PLGA-DOX) was prepared by dissolving PLGA and DOX in the mixture of dimethylformamide (DMF) and triuoroethanol (TFE). The 2% PLGA-DOX solution was introduced into the microchannels from the middle inlet at varying ow rates from 0.3125 mL h À1 to 2.5 mL h
À1
, and hydrodynamically focused into a thin stream by two rapidly owing water sheaths (20 mL h À1 for each water stream (the ow ratio, R) was 7.75 Â 10 À3 -0.059 by adjusting the ow rate of 2% PLGA-DOX solution (Table S1 †).
The origami chip in two-dimensional (2D) at geometry was rst applied to synthesize PLGA-DOX nanoparticles of different sizes by varying the ow rate of organic solution ( Fig. 1(a) ). At a low ow ratio (R # 0.059) and small Reynolds number (Re z 60), the focused narrow organic stream would rapidly mix with water through diffusion. The mixing time by diffusion (s mix,diff ) was 0.59 ms at the ow ratio of 7.75 Â 10 À3 , and prolonged to 30.86 ms with the increased ow ratio of 0.059. 7 The mixing time (s mix ) was also evaluated with a three-dimensional (3D) numerical simulation using Fluent, which was in good agreement with s mix,diff (Table S2 , see ESI †).
The precipitation of PLGA-DOX nanoparticles occurred as soon as the organic stream diffused into water streams. 17 The time of formation of PLGA-DOX nanoparticles was estimated to be around 10-54 ms, ensuring an almost complete solvent displacement of DMF and TFE (see ESI †). 13 The size of PLGA-DOX nanoparticles synthesized by the at microchannel at different ow ratios was measured using dynamic light scattering, and conrmed by scanning electron microscopy (SEM) (Fig. 2(b) and (c)). We observed that the particle size increased from 100 AE 1.18 nm to 234 AE 3.38 nm in an approximately exponential trend with the increasing ow rate of the organic stream (Fig. S2 †) . We also noted that the polydispersity index (PDI) in all measurements was less than 0.13, indicating a monodisperse dispersion of PLGA-DOX nanoparticles (Fig. S3 †) .
To further decrease the mixing time and synthesize smaller PLGA-DOX nanoparticles, we manually folded the origami chip to form a 3D geometry such as an arc or a double spiral (Fig. S1 †) . The mixing distance and mixing time inside 3D geometries were predicted by 3D models using Fluent. The simulation results indicated that the combination of hydrodynamic focusing and 3D curved microchannels could signi-cantly shorten the mixing distance and reduce the mixing time ( Fig. 3(a) and (b) and S4 †). For instance, at the ow rate of 2.5 mL h À1 (R ¼ 0.059) for organic solution, the mixing time was 16 ms in 3D arc microchannels and 14.5 ms in 3D double spiral microchannels, approximately 46% faster than that in 2D at microchannels (Table S2 † ). This was due to 3D origami structures resulting in two counter-rotating vortices perpendicular to the ow direction that could efficiently increase the mixing aer curved turns (Fig. 3(d) ). 10 This enhanced mixing resulted in the generation of small PLGA-DOX nanoparticles (#100 nm) with a monodisperse distribution (PDI < 0.06) at a high ow rate of 2.5 mL h À1 (R ¼ 0.059) inside 3D double spiral microchannels.
The prepared nanoparticles were observed by transmission electron microscopy (TEM) (Fig. 2(d) and (e)). In comparison, to prepare 100 nm nanoparticles inside 2D at microchannels, we need to use a low ow rate of 0.3125 mL h À1 for organic solution (8 times lower than that in 3D channels), while the PDI of synthesized nanoparticles was 0.13 (two times larger than that in 3D channels). Such improvement in 3D channels suggested a better throughput of the nanoparticle synthesis. Moreover, the manually folded 3D channels had smooth turns to avoid abrupt velocity changes, ensuring that no clogging occurs inside microchannels for over several hours.
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The cellular uptake of PLGA-DOX nanoparticles was compared against free DOX solution by using two human carcinoma cell lines, MCF-7 and HeLa. The PLGA-DOX nanoparticles of 100 nm in size were synthesized by 3D double spiral microchannels at 2.5 mL h À1 . The DOX concentration in nanoparticles was around 50 mg mL À1 which was determined by measuring the absorption of PLGA-DOX nanoparticle solution at 480 nm (Fig. S5 †) . The encapsulation efficiency was around 50% by using the microuidic origami chip. To achieve a nal DOX concentration of 10 mg mL À1 inside nanoparticles, the suspension was diluted by using high-glucose Dulbecco's modied Eagle's medium (DMEM). Aer co-incubation of free DOX or PLGA-DOX nanoparticles at a DOX concentration of 10 mg mL À1 with MCF-7 or HeLa cells for 4 h at 37 C, cells were washed twice with phosphate buffered saline (PBS) before uorescence observation.
19 Fig. 4(a) shows confocal uorescent microscopic images of MCF-7 and HeLa cells aer 4 h treatment. Both MCF-7 and HeLa cells incubated with PLGA-DOX nanoparticles displayed higher green uorescence intensities than those treated with free DOX, indicating an enhanced cellular uptake of PLGA-DOX nanoparticles. This might be because nanoparticles were taken up by means of an endocytic process, while free DOX permeated the cell membrane through passive diffusion.
5
To investigate the effect of PLGA-DOX nanoparticles on the cancer cell cytotoxicity, MCF-7 and HeLa cells were co-incubated with 100 nm nanoparticles of different DOX concentrations for a set time period at 37 C. Cancer cells were also treated with free DOX at equal concentrations to compare the therapeutic efficacy between the drug-loaded nanoparticles and the free drug. The viability of MCF-7 and HeLa cells incubated with PLGA-DOX nanoparticles and free DOX was measured using cell counting kit-8 (CCK-8). The changes in cell morphology as a function of incubation time were recorded with a microscope. For two different cell lines, most cancer cells treated with PLGA-DOX nanoparticles exhibited higher cytotoxicity than that of free DOX (Fig. 4(b) and (c) ). days. 20 A previous study showed that the monodisperse PLGA nanoparticles of 100 nm had an optimal performance of cellular uptake. 21 In our case, the internalized drug-loaded PLGA nanoparticles by endocytosis could provide a high local concentration of DOX, thus increasing the cell cytotoxicity. 22 In addition, free DOX diffused into cancer cells might be pumped out by p-glycoprotein due to the multi-drug resistance (MDR) effect, 19, 23 while PLGA-DOX nanoparticles could be immune from this effect.
Our microuidic origami chip with various 3D geometries has been applied to synthesize monodisperse functionalized nanoparticles through enhanced mixing in 3D microchannels. The prepared PLGA-DOX nanoparticles were around 100 nm with a monodisperse distribution, exhibiting an improved cellular uptake and anticancer efficacy. The throughput of nanoparticle synthesis varied with the ow rate of the organic solution. At a maximum ow rate of 2.5 mL h À1 for 2% PLGA-
